Search Articles

View query in Help articles search

Search Results (1 to 10 of 11 Results)

Download search results: CSV END BibTex RIS


Effects and Safety of Press-Needle Therapy for Improving Visual Function and Eye Blood Circulation in Patients With Glaucoma With Controlled Intraocular Pressure: Study Protocol for a Multicenter Randomized Controlled Trial

Effects and Safety of Press-Needle Therapy for Improving Visual Function and Eye Blood Circulation in Patients With Glaucoma With Controlled Intraocular Pressure: Study Protocol for a Multicenter Randomized Controlled Trial

Glaucoma is a leading cause of irreversible blindness worldwide [1]. Progressive degeneration of retinal ganglion cells (RGCs) and the optic nerve is the basic pathological characteristic of glaucoma [2]. Optic nerve protection is the focus of glaucoma treatment based on intraocular pressure (IOP) control. Neuroprotective targets include glutamate-induced neurotoxicity, nitric oxidase synthetase, neurotropins, calcium channel receptors, free radicals, vascular insufficiency, and the rho-kinase pathway [3].

Hongji Liu, Yan Dai, Ming Yu, Jian Zeng, Chao Wang, Sa Tan, Ming Xiong, Ran Zhang, Xuemeng Yu, Mingsong Shi, Xing Yan, Fengming Lai

JMIR Res Protoc 2025;14:e67737

The Utility of a Smartphone-Based Retinal Imaging Device as a Screening Tool in an Outpatient Clinic Setting: Protocol for an Observational Study

The Utility of a Smartphone-Based Retinal Imaging Device as a Screening Tool in an Outpatient Clinic Setting: Protocol for an Observational Study

Glaucoma, the second leading cause of permanent blindness in the United States, is the acquired loss of retinal ganglion cells within the optic nerve, resulting in the progressive loss of peripheral vision [3,4]. The 2 most common types of glaucoma in the United States are primary open-angle glaucoma and primary angle-closure glaucoma, with most patients presenting asymptomatically until the optic nerve damage is severe enough [5].

Ajay Mittal, Victor Sanchez, Navjot Singh Azad, Yaroslav Zuyev, Rafael Robles, Mark Sherwood

JMIR Res Protoc 2025;14:e52650

Diagnostic Decision-Making Variability Between Novice and Expert Optometrists for Glaucoma: Comparative Analysis to Inform AI System Design

Diagnostic Decision-Making Variability Between Novice and Expert Optometrists for Glaucoma: Comparative Analysis to Inform AI System Design

Artificial intelligence (AI) has emerged as a transformative force in optometry [1], particularly for glaucoma diagnosis. In this context, AI in optometry refers to the advanced algorithms that analyze complex data such as fundus photos and related patient data. These AI systems use techniques of image processing, computer vision, deep learning, and transfer learning to detect and diagnose glaucoma.

Faisal Ghaffar, Nadine M. Furtado, Imad Ali, Catherine Burns

JMIR Med Inform 2025;13:e63109

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial

Glaucoma is a chronic optic nerve disease involving progressive loss of retinal ganglion cells, necessitating long-term treatment with minimal side effects. Some patients may choose to supplement their conventional medical interventions with complementary or alternative medicine [1-3]. In complementary and alternative therapies, there is literature on treating glaucoma with acupuncture, auricular acupressure [4], herbal medicine [5,6], nutritional supplements [7], and Ayurvedic medicine [8].

Yi-Fang Liao, Yu-Chen Lee, Hui-Ju Lin, Yi-Ching Shao

JMIR Res Protoc 2024;13:e57888

Reflecting on Decades of Data: The Global Burden of Disease–Cochrane Project

Reflecting on Decades of Data: The Global Burden of Disease–Cochrane Project

For example, a review of ophthalmologic conditions showed that trachoma, onchocerciasis, vitamin A deficiency, and refraction and accommodation disorders were all underrepresented in the CDSR, while glaucoma, macular degeneration, and other vision loss disorders were overrepresented [5]. Other completed projects have shown poor representation of tropical diseases, while mental health and behavioral conditions are overrepresented [6,7].

Madeline Adelman, Isaac Weber

JMIR Dermatol 2024;7:e41323

Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial

Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial

Accumulating evidence indicates that melatonin has a protective effect against various ocular disorders, such as uveitis, diabetic retinopathy, glaucoma, and even optic neuritis, through different mechanisms of action [60,61,73,112-115]. The multifaceted role of melatonin in neuroprotection might imply that melatonin may possess the capacity to attenuate the harmful effects that occur in degenerative retinal diseases, such as RP.

Salvador Pastor-Idoate, Milagros Mateos-Olivares, Eva María Sobas, Miguel Marcos, Alfredo Toribio, José Carlos Pastor, Ricardo Usategui Martín

JMIR Res Protoc 2023;12:e49196

Remote Perimetry in a Virtual Reality Metaverse Environment for Out-of-Hospital Functional Eye Screening Compared Against the Gold Standard Humphrey Visual Fields Perimeter: Proof-of-Concept Pilot Study

Remote Perimetry in a Virtual Reality Metaverse Environment for Out-of-Hospital Functional Eye Screening Compared Against the Gold Standard Humphrey Visual Fields Perimeter: Proof-of-Concept Pilot Study

Glaucoma is one such leading cause of irreversible VI that is often detected late due to a lack of disease awareness and the often asymptomatic nature of early disease [8,9]. Disruptions in patient care due to the pandemic necessitated the redesigning of clinical workflows to ensure continued clinical service delivery across many medical disciplines, including ophthalmology [3,10,11].

Kang-An Wong, Bryan Chin Hou Ang, Dinesh Visva Gunasekeran, Rahat Husain, Joewee Boon, Krishna Vikneson, Zyna Pei Qi Tan, Gavin Siew Wei Tan, Tien Yin Wong, Rupesh Agrawal

J Med Internet Res 2023;25:e45044

Accuracy of Using Generative Adversarial Networks for Glaucoma Detection: Systematic Review and Bibliometric Analysis

Accuracy of Using Generative Adversarial Networks for Glaucoma Detection: Systematic Review and Bibliometric Analysis

Early phases of glaucoma have no symptoms or visual field changes [8]. As the disease progresses, a slow narrowing of the visual field can occur. If left untreated, glaucoma may contribute to total blindness [9]. Loss of vision usually begins on the eye’s side and then approaches the middle.

Ali Q Saeed, Siti Norul Huda Sheikh Abdullah, Jemaima Che-Hamzah, Ahmad Tarmizi Abdul Ghani

J Med Internet Res 2021;23(9):e27414

Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study

Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study

Glaucoma is the leading cause of irreversible blindness worldwide, affecting approximately 64 million people [1,2]. A large proportion of glaucoma cases worldwide are undiagnosed or suboptimally managed [3]. More than half of the people living with the disease in low-income countries are unaware of the condition until it progresses to an advanced stage resulting in visual impairment [4,5]. As blindness caused by glaucoma is irreversible, early detection of the disease is critical [6].

Esmael Kedir Nida, Sisay Bekele, Luc Geurts, Vero Vanden Abeele

JMIR Form Res 2021;5(9):e26602

Application of an Anomaly Detection Model to Screen for Ocular Diseases Using Color Retinal Fundus Images: Design and Evaluation Study

Application of an Anomaly Detection Model to Screen for Ocular Diseases Using Color Retinal Fundus Images: Design and Evaluation Study

Color fundus camera imaging is an essential and easy-to-master technique for detecting a variety of eye diseases, such as diabetic retinopathy (DR) [6], age-related macular degeneration (AMD) [7], glaucoma [8], cataracts [9], and myopia [10,11]. However, in most countries, especially in low-income countries or regions with insufficient medical resources, there are not enough highly skilled ophthalmologists engaged in eye screening.

Yong Han, Weiming Li, Mengmeng Liu, Zhiyuan Wu, Feng Zhang, Xiangtong Liu, Lixin Tao, Xia Li, Xiuhua Guo

J Med Internet Res 2021;23(7):e27822